Mechanism of indinavir-induced hyperbilirubinemia

Indinavir is a viral protease inhibitor used for the treatment of HIV infection. Unconjugated hyperbilirubinemia develops in up to 25% of patients receiving indinavir, prompting drug discontinuation and further clinical evaluation in some instances. We postulated that this side-effect is due to indi...

全面介紹

書目詳細資料

發表在:	Proc Natl Acad Sci U S A
Principais autores:	Zucker, Stephen D., Qin, Xiaofa, Rouster, Susan D., Yu, Fei, Green, Richard M., Keshavan, Pavitra, Feinberg, Judith, Sherman, Kenneth E.
格式:	Artigo
語言:	Inglês
出版:	National Academy of Sciences 2001
主題:	Biological Sciences
在線閱讀:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC60112/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11606755/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.231140698
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!